FindTrial
Sign In

Study on the mechanism of muscle loss in leukemia patients

Study on the mechanism of muscle loss in leukemia patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017765
Enrollment
Unknown
Registered
2018-08-13
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia

Interventions

Case series:nutrition intervention

Sponsors

Hebei Ludaopei Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. clinically diagnosed as acute lymphoblastic leukemia; 2. accepting and signing informed consent.

Exclusion criteria

Exclusion criteria: 1. chemotherapy was received for the first three months before screening; 2. combined with other major diseases such as tumor, virus (HIV, HBV, HCV) and so on; 3. Different treatment strategy was used.

Design outcomes

Primary

MeasureTime frame
16sRNA, anthropology, Blood, Food;—

Countries

China

Contacts

Public ContactJianping Zhang

Bone Marrow Transplantation (BMT) Unit, Hebei Ludaopei Hospital

zhangjianping@ludaopei.com+86 13693301478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026